Vietnam Insulin Pump Market By Type (Traditional Insulin Pumps v/s Patch Pumps), By Insulin Used (Short Acting Insulin v/s Rapid Acting Insulin), By Application (Type 1 Diabetes v/s Type 2 Diabetes), By End User (Hospitals & Clinics, Diagnostic Centers, Home Care), By Region, Competition, Forecast & Opportunities, 2019-2029F

Market Overview

Vietnam Insulin Pump Market was valued at USD 86.27 Million in 2023 and is expected to reach USD 113.32 Million by 2029 with a CAGR of 4.85% during the forecast period. 

An insulin pump is a healthcare device employed for dispensing insulin into the patient for management of diabetes mellitus, also referred to as uninterrupted subcutaneous insulin management. A traditional insulin pump mainly comprises of three components which include a processing module, a disposable reservoir for insulin, and a disposable infusion set for subcutaneous insertion. Conventional insulin pumps deliver insulin from a reservoir inside the pump through tubing to a site on the skin that is linked to a smaller pliable plastic tube (cannula). In contrast, insulin patch pumps employ a pliable plastic tube under the skin, but the insulin delivery reservoir and the cannula are integrated into a single "pod" that adheres to the skin with an adhesive patch.

According to a 2020 survey conducted in 37 countries, including Vietnam, pumps were the most common method used by doctors to administer insulin to patients, after syringes and insulin pens. According to the Ministry of Health, the diabetic population in Vietnam reached nearly 5 million in 2021, accounting for approximately 7.1% of the total adult population. Moreover, approximately 29,000 patients die due to diabetes in Vietnam every year. The insulin pump market has showcased a notable growth over recent years, which can be ascribed to certain factors. Increase in prevalence of diabetes, growth in technological advancements associated with function of insulin pumps and rise in product launches related to diabetic care with FDA approval are anticipated to register an impressive growth to Vietnam Insulin Pump Market in the forecast period.

Key Market Drivers

Increase in Prevalence of Diabetes

Diabetes is a persistent medical condition that arises when the pancreas fails to produce enough insulin or when the body is unable to use the insulin it produces efficiently. Insulin is a hormone that regulates the level of glucose in the bloodstream. Diabetes can be broadly categorized into three types which include Type 1 diabetes, Type 2 diabetes, and gestational diabetes. Individuals suffering from diabetes are vulnerable to infections caused by elevated blood sugar levels, weakened immune system, circulatory complications, and other concurrent conditions like high blood pressure, abnormal lipid metabolism, and cardiovascular diseases. Diabetes has the possibility to become an epidemic and consequently, impose significant public health and financial burden in Vietnam. Although the incidence of diabetes in remote areas remains relatively low, it is increasing. In prominent urban centers, diabetes is as prevalent as in other Western societies. A national survey was conducted in Vietnam in 2022 based on risk factors associated with type 2 diabetes and prediabetes mellitus. In this cross-sectional study, a total of 5244 individuals aged between 30 to 69 years old were enrolled.

The National Hospital of Endocrinology, Vietnam took blood samples from all participants to measure their fasting blood glucose level and conducted a 2-hour post load oral glucose tolerance test. It was observed that male participants aged 50 to 59 years old with hypertension and WHR risk had a higher prevalence of prediabetes. Diabetes was found to have a significant association with participants having hypertension. The study found that 17.9% of the participants had prediabetes and 7.3% had diabetes. The mean age of the participants was 49.62 ± 0.15 years, and more than half were female (52.0%) and had completed secondary education through high school. Among men, 23.7% were overweight or obese, and 6.6% were underweight, which was higher than the corresponding figures for women (19.9% overweight or obese and 5.0% underweight).

The WHR risk was lower among male participants (20.2%) than female participants (88.4%). The prevalence of hypertension was 38.5% among male participants and 26.8% among female participants. The proportion of male participants with prediabetes and diabetes were 7.2% and 6.4%, respectively, while the corresponding figures for female participants were 6.2% and 4.5%. Insulin pumps can dispense minute quantities of insulin on a regular basis (basal) or a bolus dose near mealtime to regulate spikes in blood glucose (blood sugar) levels after meals. This mode of delivery mirrors the body's natural release of insulin. The insulin pump can be synchronized with a continuous glucose monitor (CGM) to gain insight into how blood glucose levels change and adjust the insulin dose accordingly in certain scenarios.

 Download Free Sample Report

Technological Advancements

Due to advances in technologies such as continuous glucose monitors, traditional insulin pumps are becoming more intelligent devices that can automate insulin administration. The desire to create closed-loop systems has led to numerous collaborations between insulin pump and CGM manufacturers. Presently, Medtronic is at the forefront with its 780G system, an "advanced hybrid closed loop" system. This system enables Medtronic pumps to receive information from linked Medtronic CGMs and adjust their insulin distribution independently. In 2022, Insulet announced that the FDA authorized its Omnipod 5 Automated Insulin Delivery System for individuals aged 6 years and older with type 1 diabetes. Omnipod 5, the first tubeless automated insulin delivery system, integrates with the Dexcom G6 Continuous Glucose Monitoring (CGM) System and smartphone management to automatically regulate insulin levels and prevent hyperglycemia and hypoglycemia. Moreover, Tandem Diabetes Care obtained FDA approval for bolus insulin dosing on the t:slim X2 insulin pump via the t:connect mobile application in mid-February 2022. This achievement marked the first FDA-approved smartphone app that can initiate insulin administration on iOS and Android.

Rising Demand for Personalized Diabetes Management

The growing demand for personalized diabetes management is a key driver of the insulin pump market in Vietnam. As healthcare shifts toward more individualized care, diabetic patients are increasingly seeking tailored treatment options to better manage their condition. Insulin pumps offer a sophisticated solution, providing continuous insulin delivery that can be adjusted based on individual needs, lifestyle, and glucose levels. This customization allows for improved blood sugar control and a reduction in complications, especially for individuals with type 1 diabetes. Personalized diabetes management is also supported by technological advancements such as continuous glucose monitoring (CGM) systems, which provide real-time data on blood glucose levels. Insulin pumps integrated with CGM allow for automated insulin adjustments, making it easier for patients to manage their diabetes without constant monitoring.  As awareness of the benefits of personalized care grows, there is a rising preference for insulin pumps over traditional insulin delivery methods. This trend is also fueled by the increasing access to advanced medical devices among Vietnam’s growing middle class, which is willing to invest in personalized healthcare solutions.

Key Market Challenges

Limited Awareness and Accessibility

Limited awareness and accessibility pose significant barriers to the growth of the insulin pump market in Vietnam. Firstly, a lack of awareness among healthcare professionals and patients about insulin pumps hampers the adoption of this advanced diabetes management technology. Without adequate knowledge of the benefits and features of insulin pumps, healthcare providers may not recommend them as a treatment option, and patients may not actively seek them out. Additionally, limited accessibility to insulin pumps further exacerbates this issue, particularly in rural or remote areas where healthcare infrastructure may be underdeveloped. The lack of specialized diabetes care centers and trained healthcare professionals capable of supporting insulin pump therapy limits patients' access to these devices. Moreover, the high cost of insulin pumps presents an affordability barrier for many individuals, further limiting accessibility.

High Cost

The high cost of insulin pumps poses a significant impediment to market growth in Vietnam. Affordability is a critical factor influencing the adoption of insulin pump therapy, particularly in a country where healthcare expenses can place a considerable financial burden on individuals and families. The upfront cost of purchasing an insulin pump, along with ongoing expenses for supplies, maintenance, and training, may be prohibitive for many patients, especially those from lower-income backgrounds. Moreover, limited insurance coverage and reimbursement options for insulin pumps further exacerbate the financial barrier, forcing patients to bear the full cost out of pocket. As a result, individuals with diabetes may opt for less expensive treatment alternatives, such as insulin injections or oral medications, despite the potential benefits of insulin pump therapy in terms of improved glycemic control and quality of life.

Key Market Trends

Telemedicine and Remote Monitoring

Telemedicine and remote monitoring hold significant potential to positively influence the growth of the insulin pump market in Vietnam. As the country faces challenges in healthcare access and infrastructure, telemedicine platforms can help bridge the gap by enabling remote consultations between patients and healthcare providers. This allows individuals with diabetes, including those in rural or underserved areas, to access specialized care and guidance regarding insulin pump therapy without the need for in-person visits to healthcare facilities. Moreover, remote monitoring technologies integrated with insulin pumps enable continuous tracking of glucose levels and treatment adherence, empowering healthcare providers to remotely monitor patients' progress and intervene proactively in case of any issues.

This not only improves patient safety and outcomes but also enhances the efficiency of diabetes management by reducing the need for frequent clinic visits and hospitalizations. By leveraging telemedicine and remote monitoring solutions, healthcare providers can extend the reach of diabetes care, increase patient engagement, and ultimately drive the adoption of insulin pump therapy as a preferred treatment option for individuals with diabetes in Vietnam. However, ensuring reliable internet connectivity and promoting digital literacy among both patients and healthcare professionals will be essential to realize the full potential of these technologies in advancing diabetes care across the country.

Focus on Continuous Glucose Monitoring (CGM) Integration

The focus on continuous glucose monitoring (CGM) integration is poised to significantly influence the growth of the insulin pump market in Vietnam. CGM technology provides real-time insights into glucose levels, enabling more precise, timely adjustments to insulin therapy, which can lead to better glycemic control and a reduced risk of complications. By integrating CGM functionality into insulin pump systems, manufacturers offer users a seamless and comprehensive solution for diabetes management. This integration eliminates the need for separate CGM devices and simplifies monitoring, making it more convenient and user-friendly for individuals with diabetes. Furthermore, the combination of CGM and insulin pump therapy enables automated insulin delivery algorithms, known as hybrid, closed-loop systems, which adjust insulin doses based on real-time glucose readings, further optimizing blood sugar levels while minimizing the risk of hypoglycemia. As awareness grows about the benefits of CGM-integrated insulin pumps among healthcare professionals and patients in Vietnam, demand for these advanced technologies is expected to rise, driving market growth, and improving outcomes for individuals living with diabetes in the country.

Segmental Insights

Type Insights

Based on Type, Patch Pumps emerged as the fastest growing segment in the Vietnam Insulin Pump market during the forecast period. Patch pumps are more compact, lightweight, and discreet than traditional insulin pumps, offering enhanced comfort for patients seeking a less visible solution for diabetes management. Unlike conventional pumps, which rely on tubing and external devices, patch pumps are adhesive and attach directly to the skin, making them more convenient for extended wear, especially for those with active lifestyles. As technology advances, patch pumps now feature wireless connectivity, remote control capabilities, and integration with continuous glucose monitoring (CGM) systems, offering a more streamlined and flexible approach to diabetes management. Their smaller, tubeless design enhances comfort, making them ideal for individuals who find traditional pumps bulky. With the growing trend towards personalized healthcare, patch pumps allow users to adjust insulin delivery to meet their specific needs, driving their increasing popularity in the market.

Application Insights

Based on Application, the Type 1 diabetes emerged as the dominating segment in the Vietnam insulin pump market in 2023. Type 1 diabetes occurs when the body cannot produce insulin, requiring individuals to rely on external insulin sources, typically via injections or insulin pumps. Insulin pumps are particularly beneficial for these patients, offering a continuous insulin supply that helps maintain stable blood glucose levels and minimizes the risk of complications. Type 1 diabetes typically develops in childhood or adolescence, meaning these patients need lifelong insulin management. This ongoing need for consistent insulin therapy makes insulin pumps an ideal solution for effective diabetes management. Technological advancements in insulin pumps such as smaller, more convenient, and comfortable designs have made them even more appealing. These devices provide precise insulin delivery, improving diabetes control and appealing to Type 1 diabetes patients who require constant monitoring. Compared to traditional injections, insulin pumps deliver insulin more efficiently and consistently, mimicking the body’s natural release, leading to better glucose control and fewer complications. While Type 2 diabetes is becoming more prevalent, Type 1 diabetes still accounts for a larger share of the population requiring insulin pumps, as these patients typically need insulin therapy earlier in their treatment. Thus, the Type 1 diabetes segment continues to dominate the insulin pump market due to the sustained and direct need for insulin management.

Download Free     Sample Report

Regional Insights

By region, Southern Vietnam emerged as the leading region in the Vietnam Insulin Pump Market in 2023. The southern region, particularly cities like Ho Chi Minh City, has a higher concentration of healthcare facilities, specialized diabetes clinics, and trained healthcare professionals compared to other regions. This concentration of healthcare resources facilitates better access to insulin pump therapy and related support services, making it more convenient for individuals with diabetes to seek treatment in the southern region. Additionally, the southern region tends to have higher levels of economic development and disposable income, which may enable more individuals to afford the upfront cost of insulin pumps and ongoing expenses for supplies and maintenance. Furthermore, the southern region often serves as a hub for medical tourism and healthcare innovation, attracting investments from manufacturers and distributors of medical devices, including insulin pumps.

Recent Development

• In October 2025, Medtronic Vietnam renewed an MoU with Hue Central Hospital focused on skill-building and training, and Medtronic’s regional news listing explicitly includes insulin pumps as part of the company’s device portfolio context.
• In January 2025, Vietnam began construction of a plasma-based biopharmaceutical production facility in Thu Duc City’s high-tech park led by Binh Viet Duc Co., Ltd., and the project description included facilities for vaccine and insulin production (a local insulin-supply chain and manufacturing capacity update relevant to intensive insulin therapy ecosystems).
• In November 2024, Novo Nordisk Vietnam launched community initiatives to celebrate World Diabetes Day. These initiatives included a livestream to raise awareness of diabetes care, educational sessions to prevent complications for individuals living with diabetes, and a community cycling and walking event to highlight the role of physical activity in diabetes management.
• In July 2024, Novo Nordisk Vietnam marked a significant milestone with the first shipment of its products as a Foreign Invested Enterprise (FIE). This development underscores the company's commitment to expanding its presence in Vietnam, enhancing its local operations, and creating new employment opportunities.

Key Market Players

• Roche Vietnam Co., Ltd. 
• Medtronic Vietnam
• Abbott Laboratories GmbH
• B. Braun Vietnam Co., Ltd.
• NIPRO PHARMA VIETNAM CO., LTD.
• Novo Nordisk Pharma Operations A/S Vietnam

Report Scope:

In this report, the Vietnam Insulin Pump Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vietnam Insulin Pump Market, By Type:

o   Traditional Insulin Pumps

o   Patch Pumps

• Vietnam Insulin Pump Market, By Insulin Used:

o   Short Acting Insulin

o   Rapid Acting Insulin

• Vietnam Insulin Pump Market, By Application:

o   Type 1 Diabetes

o   Type 2 Diabetes

• Vietnam Insulin Pump Market, By End User:

o   Hospitals & Clinics

o   Diagnostic Centers

o   Home Care

• Vietnam Insulin Pump Market, By Region:

o   Southern Vietnam

o   Northern Vietnam

o   Central Vietnam

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Vietnam Insulin Pump Market.

Available Customizations:

Vietnam Insulin Pump Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Vietnam Insulin Pump Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]